CG Oncology, Inc. (CGON)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20265 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to CG Oncology, Inc.’s names, not what it holds today.
0 published
5 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jul 29, 2025 | 12,370,229 | Methods of treating bladder cancer | Pharmaceuticals | CG ONCOLOGY, INC. |
| Sep 17, 2024 | 12,090,183 | Methods of treating solid or lymphatic tumors by combination therapy | Biotechnology | CG ONCOLOGY, INC. |
| Mar 7, 2023 | 11,596,660 | Methods of treating bladder cancer | Pharmaceuticals | CG ONCOLOGY, INC. |
| Nov 15, 2022 | 11,497,781 | Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor | Biotechnology | CG ONCOLOGY, INC. |
| May 24, 2022 | 11,338,003 | Methods of treating bladder cancer with an oncolytic virus | Pharmaceuticals | CG ONCOLOGY, INC. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Oct 2, 2025 | 2025/0302897 | METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY | Pharmaceuticals | CG Oncology, Inc. |
| Feb 16, 2023 | 2023/0052537 | METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY | Pharmaceuticals | CG Oncology, Inc. · patent 12,090,183 granted from it |
| Oct 20, 2022 | 2022/0331384 | METHODS OF TREATING BLADDER CANCER | Pharmaceuticals | CG Oncology, Inc. · patent 11,596,660 granted from it |
| Sep 22, 2022 | 2022/0296658 | METHODS OF TREATING BLADDER CANCER | Pharmaceuticals | CG Oncology, Inc. · patent 12,370,229 granted from it |
| Apr 28, 2022 | 2022/0125864 | METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY | Pharmaceuticals | CG Oncology, Inc. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.